Ratto Elena, Leoncini Giovanna, Viazzi Francesca, Vaccaro Valentina, Falqui Valeria, Parodi Angelica, Conti Novella, Tomolillo Cinzia, Deferrari Giacomo, Pontremoli Roberto
Department of Cardio-Nephrology, Azienda Ospedaliera Universitaria San Martino, Genoa, Italy.
J Hypertens. 2006 Oct;24(10):2033-8. doi: 10.1097/01.hjh.0000244953.62362.41.
Arterial stiffness is a predictor of cardiovascular mortality in the general population as well as in hypertension and end-stage renal disease. We investigated the relationship between a recently proposed ambulatory blood pressure monitoring-derived index of arterial stiffness and early signs of renal damage in patients with primary hypertension.
A total of 168 untreated patients with sustained primary hypertension were studied. Ambulatory arterial stiffness index (AASI) was calculated based on 24-h ambulatory blood pressure readings. Albuminuria was measured as the albumin to creatinine ratio. Creatinine clearance was estimated using the Cockcroft-Gault formula, and the interlobar resistive index was evaluated by renal ultrasound and Doppler examination.
AASI was positively related to urinary albumin excretion and resistive index, and was negatively related to estimated creatinine clearance and renal volume to the resistive index ratio. Patients with AASI above the median (i.e. > 0.51) showed a higher prevalence of microalbuminuria and a mild reduction in creatinine clearance. Moreover, patients with microalbuminuria or a mild reduction in creatinine clearance had significantly higher AASI values compared with those without, and the greater the renal involvement, the greater the AASI. After adjusting for several potentially confounding variables, we found that each standard deviation increase in AASI (i.e. 0.16) entails an almost twofold greater risk of renal involvement.
Increased AASI is independently associated with early signs of renal damage in patients with sustained primary hypertension. These results strengthen the usefulness of AASI and ambulatory blood pressure monitoring in cardiovascular risk assessment.
动脉僵硬度是普通人群、高血压患者及终末期肾病患者心血管死亡的预测指标。我们研究了一种最近提出的基于动态血压监测得出的动脉僵硬度指数与原发性高血压患者肾脏损害早期迹象之间的关系。
共对168例未经治疗的持续性原发性高血压患者进行了研究。基于24小时动态血压读数计算动态动脉僵硬度指数(AASI)。以白蛋白与肌酐比值测量蛋白尿。使用Cockcroft-Gault公式估算肌酐清除率,并通过肾脏超声和多普勒检查评估叶间阻力指数。
AASI与尿白蛋白排泄及阻力指数呈正相关,与估算的肌酐清除率及肾体积与阻力指数比值呈负相关。AASI高于中位数(即>0.51)的患者微量白蛋白尿患病率较高,肌酐清除率轻度降低。此外,与无微量白蛋白尿或肌酐清除率轻度降低的患者相比,有此类情况的患者AASI值显著更高,且肾脏受累程度越大,AASI越高。在对多个潜在混杂变量进行校正后,我们发现AASI每增加一个标准差(即0.16),肾脏受累风险几乎增加一倍。
AASI升高与持续性原发性高血压患者肾脏损害的早期迹象独立相关。这些结果强化了AASI及动态血压监测在心血管风险评估中的作用。